Amanda Nickles Fader, M.D., a widely published and internationally recognized surgeon with a specialty in minimally invasive women’s cancer surgery and obesity and cancer, has joined Johns Hopkins Medicine as director of the Kelly Gynecologic Oncology Service and director of the Minimally Invasive Surgery Center in the Department of Gynecology and Obstetrics. She also holds the appointment of associate professor of gynecologic oncology at the Johns Hopkins University School of Medicine.
Fader has extensive training in the use of special laparascopes and robotics to perform complex gynecologic cancer operations. Prior to her appointment at Johns Hopkins, she served as an associate director of gynecologic oncology and director of robotic surgery at Greater Baltimore Medical Center.
A graduate of the University of Virginia, Fader received her medical degree from the Medical College of Virginia and took postgraduate training at the Magee-Womens Hospital of the University of Pittsburgh Medical Center and at the Cleveland Clinic.
A board-certified gynecologic oncologist, Fader’s research focuses on minimally invasive surgical innovations, clinical trials with novel cancer treatments, high-risk endometrial cancer and the role of obesity in the development of women’s cancers. Her research has been published in the Journal of Clinical Oncology, Cancer and the American Journal of Obstetrics & Gynecology. She has authored more than 65 peer-reviewed articles, and is the principal investigator on several clinical trials, including a randomized phase II trial of combination chemotherapy (carboplatin/paclitaxel) and an antibody drug (trastuzumab) for women with high-risk uterine cancer.
Fader is among a group of researchers spearheading a national initiative to improve the quality of, and costs associated with, gynecologic cancer care through the establishment of health care standards and quality indicators used in the treatment of endometrial, ovarian and cervical cancers. Johns Hopkins will be one of 15 medical institutions involved in the effort.
She serves on the editorial board of Gynecologic Oncology and the Journal of Minimally Invasive Gynecology. Additionally, Fader is active in the Gynecologic Oncology Group, has leadership roles in the Society of Gynecologic Oncology and American Association of Gynecologic Laparoscopy, and is also as a representative of Johns Hopkins to the National Comprehensive Cancer Network, where she serves on the endometrial and cervical cancer committees.
